These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30770021)

  • 41. Therapeutic efficacy of super-high-dose steroid therapy in patients with profound sudden sensorineural hearing loss: a comparison with conventional steroid therapy.
    Song MH; Jung SY; Gu JW; Shim DB
    Acta Otolaryngol; 2021 Feb; 141(2):152-157. PubMed ID: 33176548
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of low-dose intratympanic dexamethasone for sudden hearing loss.
    Günel C; Başal Y; Toka A; Eryılmaz A; Kurt Ömürlü I
    Auris Nasus Larynx; 2015 Aug; 42(4):284-7. PubMed ID: 25725564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Addition of intratympanic steroid or hyperbaric oxygen treatment to systemic steroid treatment in sudden idiopathic sensorineural hearing loss treatment, and long-term results of salvage treatment.
    Keseroğlu K; Toptaş G; Uluat A; Bayir Ö; Çadalli Tatar E; Saylam G; Korkmaz MH; Özdek A
    Turk J Med Sci; 2020 Feb; 50(1):177-183. PubMed ID: 31865663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Intratympatic budesonide injection for treatment of refractorysudden sensorineural hearing loss].
    Sun RX; Zhao Y; Liu J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 30(12):972-977. PubMed ID: 29771066
    [No Abstract]   [Full Text] [Related]  

  • 45. Effectiveness of Steroid Treatment for Sudden Sensorineural Hearing Loss: A Meta-analysis of Randomized Controlled Trials.
    Li J; Ding L
    Ann Pharmacother; 2020 Oct; 54(10):949-957. PubMed ID: 32126823
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Role of intratympanic glucocorticoid treatment in sudden hearing loss].
    Hoch S; Kremper L; Rudhart SA; Stuck BA
    HNO; 2024 Apr; 72(4):291-302. PubMed ID: 38351342
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intratympanic steroid therapy for treatment of idiopathic sudden sensorineural hearing loss.
    Bear ZW; Mikulec AA
    Mo Med; 2014; 111(4):352-6. PubMed ID: 25211869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hearing outcome does not depend on the interval of intratympanic steroid administration in idiopathic sudden sensorineural hearing loss.
    Suzuki H; Koizumi H; Ohkubo J; Hohchi N; Ikezaki S; Kitamura T
    Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3101-7. PubMed ID: 26879994
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Research progress in refractory sudden hearing loss: steroid therapy.
    Liu Y; Chen Q; Xu Y
    J Int Med Res; 2020 Jan; 48(1):300060519889426. PubMed ID: 31939327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Noninvasive intratympanic dexamethasone treatment for sudden sensorineural hearing loss.
    Zhang Q; Song H; Peng H; Yang X; Zhou J; Huang W
    Acta Otolaryngol; 2012 Jun; 132(6):583-9. PubMed ID: 22339625
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Intratympanic steroid intervention as initial therapy for sudden sensorineural hearing loss: a systematic review of reviews].
    Lai D; Huang YL; Pu JM; Liu L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Aug; 31(16):1258-1264. PubMed ID: 29798374
    [No Abstract]   [Full Text] [Related]  

  • 52. Evaluation and comparison of the efficacy of long-acting betamethasone and dexamethasone as injections in the treatment of idiopathic sudden hearing loss.
    Abdullah H; Erfanian R; Yazdani N; Hajbegloo S; Tajdini A
    Am J Otolaryngol; 2021; 42(4):102955. PubMed ID: 33588138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hearing Changes After Intratympanic Steroids for Secondary (Salvage) Therapy of Sudden Hearing Loss: A Meta-Analysis Using Mathematical Simulations of Drug Delivery Protocols.
    Liebau A; Pogorzelski O; Salt AN; Plontke SK
    Otol Neurotol; 2018 Aug; 39(7):803-815. PubMed ID: 29995001
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Role of Hyperbaric Oxygen as Salvage Therapy for Sudden Sensorineural Hearing Loss.
    Almosnino G; Holm JR; Schwartz SR; Zeitler DM
    Ann Otol Rhinol Laryngol; 2018 Oct; 127(10):672-676. PubMed ID: 30009614
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intratympanic steroid delivery by an indwelling catheter in refractory severe sudden sensorineural hearing loss.
    Zanetti D; Di Berardino F; Nassif N; Redaelli De Zinis LO
    Auris Nasus Larynx; 2018 Apr; 45(2):227-233. PubMed ID: 28511890
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intratympanic injection of dexamethasone after failure of intravenous prednisolone in simultaneous bilateral sudden sensorineural hearing loss.
    Tang B; Jia Y; Shi Z; Shen Y; Li D; Huang H; Yang B; Wang D; Feng Q
    Am J Otolaryngol; 2018; 39(6):676-678. PubMed ID: 30032906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of intratympanic and intravenous dexamethasone treatment on sudden sensorineural hearing loss with diabetes.
    Kakehata S; Sasaki A; Oji K; Futai K; Ota S; Makinae K; Shinkawa H
    Otol Neurotol; 2006 Aug; 27(5):604-8. PubMed ID: 16788418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Steroid Use for Sudden Sensorineural Hearing Loss: A CHEER Network Study.
    Witsell DL; Mulder H; Rauch S; Schulz KA; Tucci DL
    Otolaryngol Head Neck Surg; 2018 Nov; 159(5):895-899. PubMed ID: 30084293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intratympanic dexamethasone for refractory sudden sensorineural hearing loss.
    Hunchaisri N; Chantapant S; Srinangyam N
    J Med Assoc Thai; 2010 Dec; 93(12):1406-14. PubMed ID: 21344803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.